|
|
Genes that showed more than 2 fold decreased expression in oga-1(ok1207) comparing to in N2 when fed with OP50. |
The significantly expressed genes were selected based on ANOVA analysis by Partek Genomics Suite software. Genes with a p-value of <0.05 and a 2-fold or greater fold change were considered differentially expressed. |
WBPaper00046083:oga-1(ok1207)_OP50_downregulated
|
|
|
Genes that showed more than 2 fold decreased expression in ogt-1(ok1474) comparing to in N2 when fed with OP50. |
The significantly expressed genes were selected based on ANOVA analysis by Partek Genomics Suite software. Genes with a p-value of <0.05 and a 2-fold or greater fold change were considered differentially expressed. |
WBPaper00046083:ogt-1(ok1474)_OP50_downregulated
|
|
|
Genes that showed more than 2 fold increased expression in pmk-1(km25) comparing to in N2 when fed with OP50. |
The significantly expressed genes were selected based on ANOVA analysis by Partek Genomics Suite software. Genes with a p-value of <0.05 and a 2-fold or greater fold change were considered differentially expressed. |
WBPaper00046083:pmk-1(km25)_OP50_downregulated
|
|
|
Genes up-regulated after 24 hour exposure to colistin. |
Gene lists were created using a cutoff P-value of < 0.05, 2-fold change. |
WBPaper00045673:colistin_upregulated
|
|
|
Genes from N2 animals with significantly increased expression after 72 hours of treatment on growth media with 250uM allantoin in 2% DMSO. |
Analysis of gene expression data was carried out with the Affymetrix Transcriptome Analysis Console. Data preprocessing (using RMA normalization) and QC metrics were performed using Affymetrix Expression Console TM and manually inspected afterwards. Expression analysis was carried out for each two pairwise conditions. FDR statistical correction for multiple testing resulted in a slightly lower number of DEGs in most cases. P-value < 0.05 and fold change > 2.0 were used to determine differentially expressed genes. |
WBPaper00048989:N2_allantoin_upregulated
|
|
|
Genes down regulated in tax-6(ok2065) comparing to in N2. |
To identify genes that were significantly differentially expressed between each mutant and the control, linear modelling and empirical Bayes analysis was performed using the limma package. Limma computes an empirical Bayes adjustment for the t-test (moderated t-statistic), which is more robust than the standard two-sample t-test comparisons. To correct for multiple testing, Benjamin and Hochbergs method to control for false discovery rate was used. Genes with an adjusted P value of 0.05 or smaller and a fold-change in expression larger than twofold were considered differentially expressed. |
WBPaper00038172:tax-6null_down_regulated
|
|
Fed by 25 mg/ml pRJ-Fr.5 (Protease-treated Royal Jelly) for 24 h beginning at the L4 stage. |
Genes down regulated after fed by 25 mg/ml pRJ-Fr.5 for 24 h beginning at the L4 stage. |
To identify differentially regulated genes, authors eliminated all probes with absent or marginal flags and then performed a t-test with the significance level set at p < 0.05. |
WBPaper00040116:pRJ-FR.5_down_regulated
|
|
|
Genes that showed significantly increased experssion after 22.5 hours of treatment in 200nM delta7-dafachronic acid comparing with in ethanol vehicle control. |
To identify the differentially expressed genes, we applied Significance Analysis of Microarrays (SAM) analysis using the R package samr [46]. Genes with median false discovery <5% and fold changes >2.0 were considered differentially expressed. |
WBPaper00046548:dafachronic-acid_upregulated
|
|
|
Genes up or down regulated by 10e-09M of testosterone. The normalized values used were G/R ratio > 2.6 for up-regulation and G/R ratio < 0.38 for down-regulation, which corresponds to 1.39 and -1.39 log(base2) G/R ratio, respectively. |
The normalized values used were: G/R ratio > 2.6 for up-regulation and G/R ratio < 0.38 for down-regulation, which corresponds to 1.39 and -1.39 log(base2) G/R ratio, respectively. |
WBPaper00005124:testosterone_10-9M_regulated
|
